The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...
Money Talks News on MSN7h
No Doctor Needed: FDA Greenlights Self-Administered Flu VaccineThis nasal spray vaccine can be self-administered or given by a caregiver, potentially increasing vaccination rates and accessibility.
The NHS will now offer immunotherapy pill Acarizax so the body can become less sensitive to dust mites over time and halt ...
The city has installed Narcan kits at public locations after receiving them as a donation from Mothers for Awareness and ...
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...
IT’S that time of year again when we’re seemingly greeted with a new cough, sneeze or sniffle every week. But as we beat one ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT ...
School nurses, teachers or other people trained and qualified would be authorized to administer the nasal spray to a student or staff member experiencing symptoms of an opioid overdose.
"One aspect that's often overlooked is the role of medications. Blood thinners, such as aspirin or anticoagulants, can ...
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback